Cargando…

Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease

Intrastriatal administration of mesenchymal stem cells (MSCs) has shown beneficial effects in rodent models of Huntington disease (HD). However, the invasive nature of surgical procedure and its potential to trigger the host immune response may limit its clinical use. Hence, we sought to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu-Taeger, Libo, Stricker-Shaver, Janice, Arnold, Katrin, Bambynek-Dziuk, Patrycja, Novati, Arianna, Singer, Elisabeth, Lourhmati, Ali, Fabian, Claire, Magg, Janine, Riess, Olaf, Schwab, Matthias, Stolzing, Alexandra, Danielyan, Lusine, Nguyen, Hoa Huu Phuc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628278/ https://www.ncbi.nlm.nih.gov/pubmed/31208073 http://dx.doi.org/10.3390/cells8060595

Ejemplares similares

Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease
por: Novati, Arianna, et al.
Publicado: (2018)

Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals
por: Yu-Taeger, Libo, et al.
Publicado: (2022)

The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease
por: Singer, Elisabeth, et al.
Publicado: (2021)

Sexual behavior and testis morphology in the BACHD rat model
por: Novati, Arianna, et al.
Publicado: (2018)

Dynamic nuclear envelope phenotype in rats overexpressing mutated human torsinA protein
por: Yu-Taeger, Libo, et al.
Publicado: (2018)

Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease
por: Teo, Roy Tang Yi, et al.
Publicado: (2016)

Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease
por: El Massioui, Nicole, et al.
Publicado: (2016)

Neuroprotective, Neurogenic, and Amyloid Beta Reducing Effect of a Novel Alpha 2-Adrenoblocker, Mesedin, on Astroglia and Neuronal Progenitors upon Hypoxia and Glutamate Exposure
por: Melkonyan, Magda M., et al.
Publicado: (2017)

Early Deficits in Glycolysis Are Specific to Striatal Neurons from a Rat Model of Huntington Disease
por: Gouarné, Caroline, et al.
Publicado: (2013)

Differential Cellular Balance of Olfactory and Vomeronasal Epithelia in a Transgenic BACHD Rat Model of Huntington’s Disease
por: Krysewski, Lina-Marielle, et al.
Publicado: (2022)

Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients
por: Tsai, Yu-Chun, et al.
Publicado: (2012)

Reduced Motivation in the BACHD Rat Model of Huntington Disease Is Dependent on the Choice of Food Deprivation Strategy
por: Jansson, Erik Karl Håkan, et al.
Publicado: (2014)

Age-Dependent Astroglial Vulnerability to Hypoxia and Glutamate: The Role for Erythropoietin
por: Lourhmati, Ali, et al.
Publicado: (2013)

Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease
por: Che, Hong Van B, et al.
Publicado: (2011)

Intranasal Treatment of Central Nervous System Dysfunction in Humans
por: Chapman, Colin D., et al.
Publicado: (2012)

The BACHD Rat Model of Huntington Disease Shows Signs of Fronto-Striatal Dysfunction in Two Operant Conditioning Tests of Short-Term Memory
por: Clemensson, Erik Karl Håkan, et al.
Publicado: (2017)

Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease
por: Clemensson, Erik Karl Håkan, et al.
Publicado: (2017)

Correction: Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease
por: Clemensson, Erik Karl Håkan, et al.
Publicado: (2019)

The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients
por: Metzger, Silke, et al.
Publicado: (2013)

The calpain-suppressing effects of olesoxime in Huntington's disease
por: Weber, Jonasz J., et al.
Publicado: (2016)

Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice
por: El-Ayoubi, Ali, et al.
Publicado: (2023)

Keratinocytes as Depository of Ammonium-Inducible Glutamine Synthetase: Age- and Anatomy-Dependent Distribution in Human and Rat Skin
por: Danielyan, Lusine, et al.
Publicado: (2009)

Correction: Keratinocytes as Depository of Ammonium-Inducible Glutamine Synthetase: Age- and Anatomy-Dependent Distribution in Human and Rat Skin
por: Danielyan, Lusine, et al.
Publicado: (2009)

Reversal Learning and Associative Memory Impairments in a BACHD Rat Model for Huntington Disease
por: Abada, Yah-se K., et al.
Publicado: (2013)

Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington disease
por: Singer, Elisabeth, et al.
Publicado: (2017)

Reduction in Subventricular Zone-Derived Olfactory Bulb Neurogenesis in a Rat Model of Huntington’s Disease Is Accompanied by Striatal Invasion of Neuroblasts
por: Kandasamy, Mahesh, et al.
Publicado: (2015)

The Alteration of Emotion Regulation Precedes the Deficits in Interval Timing in the BACHD Rat Model for Huntington Disease
por: Garces, Daniel, et al.
Publicado: (2018)

Assessment of Motor Function, Sensory Motor Gating and Recognition Memory in a Novel BACHD Transgenic Rat Model for Huntington Disease
por: Abada, Yah-se K., et al.
Publicado: (2013)

Interplay between Endothelin and Erythropoietin in Astroglia: The Role in Protection against Hypoxia
por: Schäfer, Richard, et al.
Publicado: (2014)

Key Features in the Design and Function of Nanocarriers for Intranasal Administration of Gene Therapy in Huntington Disease
por: Fihurka, Oksana, et al.
Publicado: (2023)

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease
por: Nguyen, Huu Phuc, et al.
Publicado: (2010)

The Guanine Nucleotide Exchange Factor Kalirin-7 Is a Novel Synphilin-1 Interacting Protein and Modifies Synphilin-1 Aggregate Transport and Formation
por: Tsai, Yu-Chun, et al.
Publicado: (2012)

Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats
por: Antonsen, Bjørnar T., et al.
Publicado: (2012)

International directory of certified radioactive sources
por: Bambynek, W, et al.
Publicado: (1983)

Losartan Improves Memory, Neurogenesis and Cell Motility in Transgenic Alzheimer’s Mice
por: Drews, Henning Johannes, et al.
Publicado: (2021)

Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
por: Saft, Carsten, et al.
Publicado: (2023)

Common Neuroprotective Effects of Endothelin Receptor A Blockade and Erythropoietin During Hypoxia-Associated Cell Injury. Perspectives of Combined Treatment
por: Danielyan, Lusine, et al.
Publicado: (2006)

Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study
por: Wiest, Reiner, et al.
Publicado: (2021)

Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease
por: Faure, Alexis, et al.
Publicado: (2013)

Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta‐Analysis
por: Medina, Alex, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1i145rg6h74sfrpim9cg62ofmj